← 返回

胃癌中 ATM 与 ARID1A 的关联

英文原题:Association of ATM and ARID1A in gastric carcinoma.

查看英文原题

Association of ATM and ARID1A in gastric carcinoma.

PubMed 2024/10/19(内容时间) Pathol Res Pract Q1 · IF 3.7(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

研究概要

GC 中 ATM 低表达显示出与 ARID1A 低表达强烈相关的特征性临床病理特征。ATM 突变也与 ARID1A 突变相关,突显了 GC 中 ATM 与 ARID1A 之间的相互作用,并提示了一个潜在的治疗靶点。

研究思路结论见上方概要

共济失调毛细血管扩张突变(ATM)基因参与双链DNA断裂的修复,是DNA损伤修复通路的组成部分。同时存在ARID1A和ATM突变或低表达的肿瘤,其TIL(肿瘤浸润淋巴细胞)数量增加,预后良好。然而,ATM与ARID1A在胃癌(GC)中的关系尚不清楚。

我们使用亚洲癌症研究组的mRNA表达数据构建了组织微阵列(N = 249)。三星医疗中心(SMC)的下一代测序(NGS)数据库(N = 813)用于比较基因改变。组织微阵列用于ATM和ARID1A免疫组化,表达被分类为“低”和“高”。TCGA-STAD的NGS数据(N = 431)作为独立队列用于基因改变验证。

在GCs中,32.1%(80/249)的病例显示ATM蛋白低表达(ATM low),20.9%(52/249)显示ARID1A低表达(ARID1A low)。ATM low与年龄较大(P <.01)、肿瘤大体类型(P =.02)、组织学(P <. 01)、神经周围侵犯发生率较低(P =.04)、疾病分期较低(P <.01)、微卫星高度不稳定(P <.01)以及ARID1A low(P <.01)显著相关。此外,SMC NGS数据库中的GCs显示,ATM突变与ARID1A突变显著相关(P <.01),这一发现在TCGA-STAD验证队列中仍然显著(P <.01)。

展开英文摘要原文

The ataxia telangiectasia mutated (ATM) gene is involved in the repair of double-stranded DNA breaks and a component of the DNA damage repair pathway. Tumors with mutations or low expression of both ARID1A and ATM exhibit increased numbers of tumor-infiltrating lymphocytes and a favorable prognosis. However, the relationship between ATM and ARID1A in gastric carcinoma (GC) is unclear.

We used the mRNA expression data from the Asian Cancer Research Group to construct tissue microarrays (N = 249). Next-generation sequencing (NGS) databases of Samsung Medical Center (SMC) (N = 813) were used to compare genetic alterations. Tissue microarrays were used for ATM and ARID1A immunohistochemistry, and expressions were categorized as "low" and "high." NGS data from TCGA-STAD (N = 431) were used as independent cohorts for genetic alterations validation.

In GCs, 32.1 % (80/249) of the cases showed low ATM protein expression (ATM low ) and 20.9 % (52/249) showed low ARID1A expression (ARID1A low ). ATM low was significantly associated with older age (P <.01), gross type of tumor (P =.02), histology (P <. 01), lower incidence of perineural invasion (P =.04), lower disease stage (P <.01), microsatellite instability-high (P <.01), and ARID1A low (P <.01). Furthermore, GCs in the SMC NGS database showed that ATM mutations were significantly correlated with ARID1A mutations (P <.01), and this finding remained significant in TCGA-STAD validation cohort (P <.01).

ATM low in GCs shows a characteristic clinicopathological feature that correlates strongly with ARID1A low . ATM mutation was also associated with ARID1A mutations, highlighting the interactions between ATM and ARID1A in GC and suggesting a potential therapeutic target.

论文信息

作者
Hwang I、Lee S、Kim Y、Kim DG、Kang SY、Ahn S、Lee J、Kim KM
第一作者单位
Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine,&#xa0;Seoul,&#xa0;Republic of Korea.South Korea
通讯作者单位
Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine,&#xa0;Seoul,&#xa0;Republic of Korea; Center of Companion Diagnostics, Samsung Medical Center,&#xa0;Seoul,&#xa0;Republic of Korea. Electronic address: kkmkys@skku.edu.South Korea
期刊
Pathology, research and practice2024 Nov
原文标识
PubMed 39476606 · DOI 10.1016/j.prp.2024.155664